Anti-Human Siglec-2/CD22 Reference Antibody (Epratuzumab, RUO)
Overview
| Catalog No. |
HB011036 |
| Brand |
abinScience |
| Tested applications |
FCM |
| Species reactivity |
Human |
| Form |
Liquid |
| Storage buffer |
0.01M PBS pH 7.4 |
| Purity |
>95% purity as determined by SDS-PAGE. |
| Isotype |
IgG1-nd |
| Applications |
ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Target |
Sialic acid-binding Ig-like lectin 2, Siglec-2, CD22, T-cell surface antigen Leu-14, BL-CAM, SIGLEC2, B-lymphocyte cell adhesion molecule, B-cell receptor CD22 |
| Purification |
Protein A/G purified from cell culture supernatant. |
| Endotoxin level |
< 10 EU/mg |
| Expression system |
Mammalian cells |
| Accession |
P20273 |
| Stability and Storage |
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Alternative name | 90Y-DOTA-hLL2, 90Y-epratuzumabtetraxetan, AMG-412, 90Y-hLL2, hLL2, 205923-57-5 |
| Note |
For research use only. Not suitable for clinical or therapeutic use. |
| Isotype Control |
Human IgG1 Recombinant Isotype Control Antibody (13R4) (HV080507) |
Images